Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
1.110
-0.040 (-3.48%)
At close: Oct 8, 2026, 4:00 PM EDT
1.000
-0.110 (-9.91%)
Pre-market: Oct 9, 2026, 5:17 AM EDT
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $15.08 million as of October 8, 2026. Its market cap has decreased by 73.13% in one year.
Market Cap
15.08M
Enterprise Value
10.56M
1-Year Change
-73.13%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $15.08M, a decrease of -79.30%. That is a compound annual growth rate of -27.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 15.08M | -74.48% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Estrella Immunopharma | 18.66M |
| Jasper Therapeutics | 18.64M |
| Palatin Technologies | 17.45M |
| Lipocine | 17.31M |
| NewcelX | 17.10M |
| Marker Therapeutics | 16.84M |
| Dyadic International | 16.52M |
| BioCardia | 16.05M |